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Abstract Stevia is a genus of approx. 200 species of
herbs and shrubs from the family Astraceae. One of
the representatives of the genus is sweetleaf Stevia
rebaudiana, formerly called Eupatorium rebaudianum
Bertoni (Yadav et al. in Can J Plant Sci 91:1–27, 2011).
S. rebaudiana Bertoni has been known for many
centuries by indigenous tribes of South America, who
called it ‘‘kaa-hee’’ (sweet herb). South American
Indians used stevia both as a sweetener and as a
medicinal plant. Folk medicine of Paraguayan
indigenous tribes recommends it particularly as a
substance strengthening the heart, the circulatory
system and regulating blood pressure. Sweetleaf is
also used in liver disease, stomachache, gastric
hyperacidity and as a mild agent stimulating the
nervous system. It exhibits antibacterial, antifungal
and anticaries properties. Nutritive and health-pro-
moting properties of stevia are presently being
investigated in many research centres. The aim of
this paper is to present the health-promoting value of
S. rebaudiana as stevia leaf powder, crude leaf extract
or steviol glycosides (highly purified stevioside,
rebaudioside A).
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1 Health-promoting properties of stevia
The energy value of stevia is approx. 2.7 kcal/g dry
matter (Savita et al. 2004), which is comparable to
other low-caloric commercially available intensive
sweeteners. Stevia may substitute commonly used
sucrose, thus reducing the consumption of simple
sugars, which is advisable in the prevention of car-
ies, obesity, type 2 diabetes and other civilisation-
related diseases. Steviol glycosides are not digested
in the alimentary tract, they are broken down to
steviol and glucose by the bacteria colonising the
large intestine. Glucose released is not absorbed to
the bloodstream, but metabolized by the intestinal
flora. In turn, steviol is transformed to glucuronide
in the liver and released in this form with urine and
faeces (Atteh et al. 2011). Acceptable daily intake of
steviol glycosides, expressed as steviol equivalents,
was established at 4 mg/kg b.w. per day. However,
most researchers are of the opinion that a daily
intake of 5 mg/kg b.w. per day of steviol glycosides
is safe and has no teratogenic or carcinogenic
effects (Chatsudthipong and Muanprasat 2009;
Awney et al. 2011). A study by Awney et al. (2011)
conducted on young male rats showed that only a
dose as high as 1500 mg/kg b.w. exhibits toxic action
and has a negative effect on hematological and
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2 Hypotensive effect
The hypotensive effect of stevioside consists in
blocking the inflow of Ca2? ions to vascular smooth
muscle cells, which promotes vasodilation as well as
reduces total peripheral resistance and volume of
extracellular fluid as a result of increased diuresis and
natriuresis (Bugaj et al. 2013). Savita et al. (2004)
conducted studies on the effect of stevia leaf powder
on blood glucose level and arterial pressure in six
patients with type 2 diabetes and eight patients with
arterial hypertension. The participants of the exper-
iment consumed sweet snacks with an addition of
stevia leaf powder at 0.5–1.0 g per 100 g final product
for 30 days. At the same time, they were advised to
slightly modify their diet. Stevia was found to have no
effect on blood glucose level, blood pressure, insulin
or the lipid profile (Savita et al. 2004). In contrast, the
hypotensive effect of stevioside was observed in a
study by Chan et al. (2000) conducted with the par-
ticipation of 106 women aged 28–75 years suffering
from hypertension (diastolic blood pressure
95–100 mm Hg), who for 1 year were administered
0.25 g stevioside three times daily. As a result systolic
and diastolic blood pressure of these women
decreased already after 7 days by 14 and 14.3 mm Hg.
The authors (Chan et al. 2000) stated that the
administration of steviosides might be an alternative
or adjunctive treatment in arterial hypertension.
They also observed that oral administration of ste-
viosides does not alter BMI values or biochemical
parameters in blood. Arterial tension was also
observed to decrease by approx. 7 % in a study by
Barriocanal et al. (2008) in a group of patients con-
suming stevioside in comparison to the control
administered placebo. This effect was permanent and
was maintained for up to 2 years. Moreover, the
incidence rate of left ventricular hypertrophy was
lower in the experimental group than in the control.
The hypotensive effect was also shown in studies on
dogs and rats administered 0.750 mg steviol glyco-
sides or placebo daily. Stevioside intervention caused
a considerable reduction of diastolic and systolic
blood pressure. Similar results were also reported in
other studies (Hsieh et al. 2003; Lee et al. 2001; Liu
et al. 2003). The hypotensive effect of steviosides
obtained from Stevia rebaudiana Bertoni can be
observed only in individuals suffering from arterial
hypertension. This effect was not observed in healthy
individuals (Geuns 2003). Apart from normalisation
of blood pressure, the effect of stevia whole leaves
powder on heart rate regulation was also reported
(Shivanna et al. 2013). It results from the analysis of
literature data that only long-term (1–2 years) intake
of stevia may effectively reduce arterial blood pres-
sure (Ulbricht et al. 2010; Yang et al. 2004). No such
effect was recorded in short-term studies lasting for
1–2 months. Maki et al. (2008) observed no effect of
rebaudioside A intake at 1000 mg/kg b.w. on arterial
blood pressure in patients with normal and low
arterial pressure. Metaanalysis of the existing reports
does not confirm significant hypotensive effects of
stevia glycosides on systolic blood pressure vs. pla-
cebo, while appreciable lowering effects on diastolic
blood pressure and blood glucose level have been
observed (Onakpoya and Heneghan 2014).
3 Hypoglycemic effect
Stevia rebaudiana Bertoni has been used as a hypo-
glycemic substance for hundreds of years in
Paraguayan and Brazilian medicine. In 1986, obser-
vations were conducted on 16 healthy individuals
drinking aqueous extracts of 5 g S. rebaudiana leaves
or arabinose solution for 3 days at 6-h intervals.
Glucose tolerance tests were conducted before and
after intervention. An increased glucose tolerance
was observed among the individuals administered
stevia extracts (Curi et al. 1986). The hypoglycemic
action of stevia glycosides was confirmed in a study
by Gregersen et al. (2004) conducted with twelve
participants (four women and eight men). The ana-
lyses were conducted on patients with at least a
4-year history of type 2 diabetes, who were supple-
mented daily with 1 g stevioside or 1 g maize starch
added to a meal. A lesser increase in postprandial
glycemia and the insulin index was observed in the
group of individuals administered steviosides. Similar
conclusions were presented by Taiwanese research-
ers, who investigated the effect of steviol glycosides
on the metabolism of glucose and insulin in two
groups of diabetic rats (Chen et al. 2005). In the first
group, hyperglycemia was induced using Streptozo-
tocin, while in the other group diabetes was induced
by administering fructose (insulin-dependent dia-
betes). Stevioside intake resulted in a reduced insulin
resistance in these animals and a simultaneous sup-
pression of glucagon secretion. Stevioside is capable
of reducing the amount of glucagon secreted, prob-
ably thanks to the increased mRNA expression of
carnitine palmitoyltransferase, peroxisome prolifera-
tor-activated receptor alpha (PPAR-alpha) and
stearoyl-CoA desaturase (Chen et al. 2005; Thomas
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and Glade 2002). A study by Jeppesen et al. (2003)
conducted on GK rats (a non-obese Wistar substrain
which develops type 2 diabetes mellitus early in life)
showed that intake of 0.025 g/kg b.w. stevioside has a
hypoglycemic effect. This effect is ascribed to an
increased secretion of insulin and induction of genes
associated with glycolysis. Stevioside does not only
turn out to be a substance exhibiting a hypoglycemic
action, but a similar effect may also be ascribed to
rebaudioside A, which was confirmed by Danish
researchers when investigating the effect of this
compound on the release of insulin from pancreatic
islets (Abudula et al. 2004). It was found that
stimulation of insulin secretion is dependent simul-
taneously on the dose of stevioside and the presence
of extracellular Ca2? ions. Mohd-Radzman et al.
(2013) observed that stevioside has direct effects on
3T3-L1 insulin sensitivity via increase glucose uptake
and enhanced expression of proteins involved in
insulin-signaling pathway. Increased insulin secre-
tion is connected with the closure of ATP-dependent
potassium channels, which results in the depolarisa-
tion of pancreatic beta cells and activation of Ca2?
channels. Saravanan et al. (2012) evaluated the effect
of rebaudioside A on the activity of hepatic enzymes
participating in carbohydrate metabolism in rats
with induced diabetes. Those authors showed that
rebaudioside A considerably reduces blood glucose
concentration and exhibits a protective action
towards the pancreas. The hypoglycemic action of
rebaudioside A and stevioside may be explained by
similarities in their structure. Holvoet et al. (2014)
observed that glycosides of stevia improve metabo-
lism of glucose, fat catabolism, bile acids metabolism,
storage and transport of lipids in the liver of insulin
resistant obese mice.
4 Anti-inflammatory and antimicrobial action
Boonkaewwan et al. (2006) investigated anti-inflam-
matory and immunomodulatory effects of steviosides
and their metabolites on THP-1 cells. It was found that
stevioside significantly inhibits lipopolysaccharides
which strongly enhance the generation of proin-
flammatory cytokines: IL-beta (interleukine-1b) and
TNF-alpha (tumor necrosis factor-a) by macrophages
and monocytes. Stevioside moderately stimulates the
release of TNF-a and IL-1b in THP-1 cells cultures with
no addition of lipopolysaccharide (LPS) through
interaction with the toll-like receptor 4 (TLR4), the
key receptor for LPS of Gram-negative bacteria. This
means that in case of infection stevioside prevents
the development of undesirable effects of the
inflammatory response. In healthy individuals, the
activity of monocytes is improved. Mizushina et al.
(2005) showed that isosteviol, as product by acid
hydrolysis of the steviol glycoside, strongly inhibits
DNA polymerase and topoisomerase II, in this way
delaying the growth of three types of cancer cells.
Yingkun et al. (2013) conducted experiments on male
BALB/c mice, which were administered stevioside or
dexamethasone 1 h before nasal instillation of
lipopolysaccharide, causing acute lung injury. It was
observed that stevioside limited the lipopolysaccha-
ride-induced lung injury and inhibited the
production of proinflammatory cytokines, expression
of cyclooxygenase II, inducible NO synthase as well as
phosphorylation of IjB alpha and NF-jB. Wang et al.
(2014a) observed anti-inflammatory and anti-apop-
totic effects of stevioside on mice in which mammary
gland epithelium was infected with Staphylococcus
aureus (MMECs). The same group of researchers
reported that intraperitoneal injection of stevioside
dose-dependently decreases expression of TNF-a, IL-1b
and IL-6 via inhibition of phosphorylation of protein
NF-jB and MAPK signaling pathways, whereas their
mRNA expression was not obviously changed (Wang
et al. 2014b).
Diterpene glycosides contained in stevia have
bacteri- and fungicidal properties, which may be
used in the prevention of caries and colds as well as
treatment of wounds, burns and ulcerations. The
anti-caries effect of stevia glycosides was shown in a
study by Brambilla et al. (2014) conducted on 20
volunteers, who at adequate time intervals rinsed
their mouth for 1 min with three solutions contain-
ing 10 % stevioside, rebaudioside and sucrose,
respectively. It was observed that after rinsing with
the sucrose solution the pH of plaque was much
lower than in the case of stevia-derived solutions.
Additionally it was shown that stevioside inhibits the
development of Streptococcus mutans responsible for
caries development (Brambilla et al. 2014). Gamboa
and Chaves (2012) also investigated antibacterial
activity of stevia against bacterial strains from the
genera Lactobacillus and Streptococcus. Ajagan-
nanavar et al. (2014) observed that alcoholic extracts
of stevia exert higher antibacterial activity against
Streptococcus mutans and Lactobacillus acidophilus in
comparison to aqueous extracts. Siddique et al. (2014)
showed the antimicrobial activity of extracts from S.
rebaudiana leaves against various bacterial and fun-
gal pathogens (excluding Bacillus cereus and Bacillus
megaterium). Stevia extracts also exhibit antiviral
activity and are potential antirotavirus inhibitors.
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According to Takahashi et al. (2001), substances con-
tained in stevia inhibit replication of four human
rotavirus serotypes in vitro. In a study by Shivanna
et al. (2013) conducted on 80 Wistar rats an advan-
tageous effect of stevia whole leaf powder was shown
in alleviation of liver and kidney diseases as well as
oxidative stress. The latest study by Deshmukh and
Kedari (2014) showed that methanolic and ethanolic
extracts of S. rebaudiana exhibit anticancer activity in
relation to the Caco-2 cell line.
Recently anti-neoplastic properties of S. rebaudiana
Bertoni compounds have been investigated by some
researchers (Mann et al. 2014; Vasˇko et al. 2014;
Khaybullin et al. 2014). Khaybullin et al. (2014) found
that isosteviol derivatives possess cytotoxic activity on
tumor cells derived from primary and metastatic
cancer cells.
5 Safety of application in foodstuffs
Stevia rebaudiana Bertoni belongs to the Asteraceae
(Compositae) family, like ragweed, goldenrod,
chrysanthemum, echinacea, chamomile, lettuce,
sunflower and chicory. Based on this common tax-
onomy, some popular media have issued food
warnings alleging the potential for stevia allergy. A
comprehensive literature review was conducted to
identify all data available related to allergic responses
following the consumption of stevia extracts or
highly purified steviol glycosides. Hypersensitivity
reactions to stevia in any form appear to be rare.
Therefore, there is little substantiated scientific evi-
dence to support warning statements to consumers
about allergy to highly purified stevia extracts (Urban
et al. 2015).
The primary objective of stevia use in food is to
reduce its energy value by reducing the content of
simple sugars in the product. For years, steviol gly-
cosides have been used as sweeteners in many
countries worldwide. In 2008, the Joint FAO/WHO
Expert Committee on Food Additives (JECFA) con-
cluded from the research results available that steviol
glycosides obtained from S. rebaudiana are safe for
human health and authorised their use in the USA.
The European Food Safety Agency (EFSA) evaluated
the safety of steviol glycosides obtained from leaves
of S. rebaudiana Bertoni as sweeteners and estab-
lished the acceptable daily intake (ADI) of steviol
glycosides given as steviol equivalents at 4 mg/kg
b.w. per day (EFSA 2010). This opinion was confirmed
in November 2011 by the final decision of the Euro-
pean Commission accepting sweeteners derived from
stevia for use in food. The Regulation of the Euro-
pean Commission no. 1131/2011 of 11 November 2011
presented maximum levels of steviol glycosides
(E960) in food expressed as steviol equivalents in mg/
kg product. Steviol equivalents are calculated based
on conversion coefficients of steviol glycosides to
steviol in the alimentary tract. These coefficients for
rebaudioside A and stevioside amount to 0.33 and
0.4, respectively (Carakostas et al. 2008).
6 Conclusion
Stevia rebaudiana Bertoni has an increasingly exten-
sive range of applications worldwide not only as a
sweetener, but also as a food additive reducing the
energy value of food products. Despite numerous
studies confirming health-promoting properties of
stevia and its potential applications as an adjunctive
substance in treatment of many chronic diseases,
further research is required to determine interactions
of stevia metabolites with food components and to
corroborate the acceptable daily intake of this food
additive.
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